Background: Using magnetic resonance imaging (MRI) and resting-state functional magnetic resonance imaging (rsfMRI) to explore the mechanism of brain structure and function in unmedicated patients with major depressive disorder (MDD). Patients and methods: Fifty patients with MDD and 50 matched healthy control participants free of psychotropic medication underwent high-resolution structural and rsfMRI scanning. Optimized diffeomorphic anatomical registration through exponentiated lie algebra and the Data Processing Assistant for rsfMRI were used to find potential differences in gray-matter volume (GMV) and regional homogeneity (ReHo) between the two groups. A Pearson correlation model was used to analyze associations of morphometric and functional changes with clinical symptoms. Results: Compared to healthy controls, patients with MDD showed significant GMV increase in the left posterior cingulate gyrus and GMV decrease in the left lingual gyrus (P,0.001, uncorrected). In ReHo analysis, values were significantly increased in the left precuneus and decreased in the left putamen (P,0.001, uncorrected) in patients with MDD compared to healthy controls. There was no overlap between anatomical and functional changes. Linear correlation suggested no significant correlation between mean GMV values within regions with anatomical abnormality and ReHo values in regions with functional abnormality in the patient group. These changes were not significantly correlated with symptom severity. Conclusion: Our study suggests a dissociation pattern of brain regions with anatomical and functional alterations in unmedicated patients with MDD, especially with regard to GMV and ReHo.
Introduction
By the year 2020, major depressive disorder (MDD) will become the second leading cause of global disease burden. 1 It is characterized by a persistent depressed mood, alterations in motivation, and pervasive feelings of guilt and worthlessness, and will affect approximately 15% of the general population. 2 Although the etiology and pathogenesis of depression is still unclear, the rapid development of neuroimaging technologies have provided improved methods and made it possible to explore brain structure and functional abnormalities in MDD patients.
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Yang et al cortex volume has been shown to be negatively correlated with risky choices in patients with MDD. 14 In addition, decreased GMV of the cingulate cortex has been associated with decreased cognitive performance in patients with depression. 15 These findings imply that GMV abnormalities in patients with depression may be correlated with clinical symptoms. In this study, we used magnetic resonance imaging (MRI) with voxel-based morphometry (VBM), applying the diffeomorphic anatomical registration through exponentiated lie algebra (DARTEL) procedure to investigate the change in GMV in patients with MDD and the relationship between clinical variables.
Resting-state functional MRI (rsfMRI) scans performed on patients who were in a relaxed state of mind with eyes closed has aroused increasing interest since the study of Biswal et al. 16 Regional homogeneity (ReHo), a frequently used method, is conducted to analyze the similarities of intraregional time series across the whole brain. Moreover, ReHo reflects the temporal synchrony of spontaneous blood oxygen level-dependent signal rather than its density. Therefore, abnormal ReHo may be relevant to changes in temporal aspects of neural activity in regional areas, and can be used to detect abnormal activity in whole-brain regions of psychiatric disorders in the resting state.
As a matter of fact, ReHo has been widely used to explore the pathophysiology of neuropsychiatric disorders, such as Parkinson's disease, 17 schizophrenia, 18 attention deficit/ hyperactivity disorder, 19 autism, 20 anxiety, 21 and MDD. 22 As reported in previous studies, MDD had been associated with abnormal neural activity in some brain regions implicated in emotional regulation, such as the dorsal prefrontal cortex, the amygdala, and other regions. 8, 23 A meta-analysis of neuroimaging studies focused on ReHo of patients with depression found that the medial prefrontal cortex was increased in depression. 24 In addition, ReHo alterations in depression patients have been identified in many other brain regions, including the anterior cingulate cortex 25 or precuneus, and have been shown to correlate with symptom severity or disease duration. 26 A previous study showed that besides patients with MDD, those at high risk for MDD also exhibited significantly decreased ReHo in the right insula and in the left cerebellum. 22 Furthermore, Wang et al found that patients with MDD displayed a ReHo decrease in the right precuneus after treatment with escitalopram. 27 These findings showed that functional alterations in brain regions can be identified using ReHo in patients with MDD. Moreover, ReHo changes in the precuneus have been found in response to pharmacological treatment in MDD. In this study, we detected regional neural activity in medication-free patients with MDD in the resting state by using the ReHo method.
Multimodal neuroimaging techniques, such as structural MRI and rsfMRI, were used to explore the pathophysiology of depression. Nevertheless, it is unclear whether these anatomical alterations and functional deficits contribute independently to depression. Previous studies have shown that anatomical and functional brain abnormalities are dissociated in schizophrenia and might contribute independently to the pathophysiology of schizophrenia, [28] [29] [30] [31] while one study reported decreased association between functional activity and regional GMV in schizophrenia. 32 Recently, a study reported that the dissociation of anatomical and functional abnormalities was also observed in patients with MDD. 33 To our knowledge, this is the first study that investigated anatomical and functional alterations simultaneously in the same depression patients. The authors investigated abnormalities of GMV and amplitude of low-frequency fluctuation (LFF) in patients with MDD, and found that brain structural and functional deficits contribute independently to depression.
The aim of the current study was to explore the association between brain functional and anatomical deficits in unmedicated patients with MDD. Based on the aforementioned studies, [28] [29] [30] [31] 33 we hypothesized that functional and anatomical abnormalities in brain regions would be observed in different brain areas in medication-free patients with MDD. To test this hypothesis, we investigated abnormalities of GMV and ReHo in unmedicated patients with depression, the interrelationship between these alterations, and their relationship with clinical variables.
Patients and methods Participants
Depressive patients included in our study generally visited their psychiatrist because of depressive relapse after quitting medication. At that time, their physician either asked him/ her to contact us or asked his/her permission to be referred to us. Fifty unmedicated patients with MDD were recruited from the Psychiatry Department of West China Hospital of Sichuan University. Major depression was diagnosed by two qualified psychiatrists (XM and ML) using the Structured Clinical Interview according to the Diagnostic and Statistical Manual of Mental Disorders (DSM)-IV criteria. 34 All patients were assessed and scanned as soon as possible (usually within 3 days) to prevent treatment delay. Patients who had taken psychotropic medications in the previous 3 months before scanning were excluded. In addition, exclusion criteria included age younger than 18 years or older than 60 years, 
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anatomical and functional brain abnormalities in MDD history of loss of consciousness, mental retardation, cardiovascular disease, schizophrenia, bipolar disorder, anxiety disorder, neurological illness, and alcohol or drug abuse. Fifty demographically similar (age-, sex-, and education-matched) healthy controls were recruited by poster advertisements from the local area. Healthy controls were interviewed using the Structured Clinical Interview for DSM-IV, non-patient edition, 35 to assure that none of them had a current or past history of depression or other major physical or neurological illness, or substance abuse.
All participants signed an informed consent form prior to participation in the study. This study was approved by the Ethics Committee of Sichuan University, and was conducted according to the Helsinki Declaration.
haM-D and haM-a questionnaires
All patients were scored by two qualified psychiatrists (XHM and MLL) according to the 17-item Hamilton Depression Rating Scale (HAM-D) and 14-item Hamilton Anxiety Scale (HAM-A) to assess the severity of symptoms. Patients with scores $18 on the HAM-D were included in our study.
Mri data acquisition
All scanning was performed on a 3.0 T MR scanner (Achieva; Philips, Amsterdam, the Netherlands) using an eight-channel phased-array head coil. Foam padding and earplugs were used to minimize head movement and scanner noise. During scanning, participants were often reminded to remain motionless with eyes closed, without falling asleep, and without thinking of anything special (confirmed by subjects immediately after the experiment).
High-resolution T1 images were acquired by 3-D magnetization-prepared rapid gradient-echo sequence as follows: repetition time 8.37 ms, echo time 3.88 ms, flip angle 7°, in-plane matrix resolution 256×256, field of view 24×24 cm 2 , and number of slices 188. A total of 240 volumes of echo-planar images were obtained axially with a gradientecho echo-planar imaging sequence with the following parameters: repetition time 2,000 ms, echo time 3.711 ms, flip angle 7°, in-plane matrix resolution 256×256, field of view 256×256 mm 2 , and number of slices 38. None of the participants had more than 2 mm maximum displacement in x, y, or z and 2° of angular motion during the whole MRI scan. For each participant, the fMRI scanning lasted for 8 minutes and 6 seconds, and 240 volumes were obtained.
image processing and analysis
All structural data were processed using the DARTEL 36 toolbox with the Statistical Parametric Mapping software package (SPM8; http://www.fil.ion.ucl.ac.uk/spm). VBM preprocessing involved five steps, and followed the standard approach of Ashburner. 36 The modulated gray-matter images were smoothed with an isotropic Gaussian kernel of 6 mm full width at half maximum to be used in statistical analysis.
ReHo analysis was performed with the Data Processing Assistant for Resting-State fMRI 37 in MatLab (MathWorks, Natick, MA, USA). Individual ReHo maps were generated by calculating Kendall's coefficient of concordance (KCC) of the time series of a given voxel with those of its nearest neighbors (26 voxels) in a voxel-wise analysis. 38 Zang et al described the formula for calculating the KCC value in their study. 39 After calculating the ReHo map voxel by voxel, the resulting fMRI data were then spatially smoothed with a Gaussian kernel of 6×6×6 mm 3 full width at half maximum. While functional connectivity approaches measure the temporal correlation of low-frequency fluctuations (LFFs) between remote brain regions, ReHo measures the local synchronization of spontaneous fMRI, 40 which is based on the assumption that LFFs within a functional cluster will synchronize with neighboring voxels. 24 
statistical analysis
Based on SPSS version 17.0, the χ 2 test for categorical data and Student's t-test for continuous variables were used to evaluate differences in demographic characteristics between patients and controls. Two sample t-tests contained in SPM8 were used to test the differences in GMV and ReHo values between patients and controls. Confounding factors were regressed out, including age, sex, education years, and total volume of gray matter and white matter of each subject. Anatomical analyses yielded statistical parametric maps based on a voxel-level height threshold of P,0.001 (uncorrected for multiple comparisons). The statistical results of ReHo were corrected using the AlphaSim program, which is based on Monte Carlo simulations (http://afni.nimh.nih.gov/pub/dist/ doc/manual/AlphaSim.pdf). The statistical threshold for this analysis was set at P,0.001.
To determine the overlap between GMV and ReHo results, brain regions with abnormal GMV or ReHo were overlaid on the same template. Furthermore, brain regions with abnormal GMV and ReHo were identified as regions of interest. Mean values of GMV and ReHo were extracted for further Pearson's correlation analysis between these abnormal values and the HAM-D or HAM-A scores in the patient group. Confounding factors were regressed out, including age and sex. (Figure 2 , Table 2 ).
association between morphometric and functional results
We overlaid the regions with abnormal GMV or ReHo values on the same template, but found no overlap of brain regions. Linear correlation suggested no significant correlation between mean GMV values within regions with anatomical abnormalities and ReHo values in regions with functional abnormality in the patient group.
correlations between clinical variables and functional/anatomical alterations
The structural and functional brain alterations in MDD did not significantly correlate with symptom severity in the patient group (Table 3) .
Discussion
Compared to healthy controls, patients with MDD showed significantly increased GMV in the left PCG and decreased GMV in the left LG. Functional analysis showed that patients had increased ReHo values in the left precuneus and decreased ReHo values in the left putamen. No overlap of brain regions with structure or functional alterations was observed in patients. Moreover, no significant correlation between mean GMV values or ReHo values of the regions and clinical variables was found in the depressed group.
In our study, VBM-DARTEL identified increased GMV in the left PCG and decreased GMV in the left LG. Previous studies may have found gray-matter reduction in the CG, identifying these abnormalities in elderly depressed patients, 41 depressed adolescents, 42 and patients with psychotic depression, 43 while these structural brain abnormalities were particularly found in patients with a longer course of illness. In addition, depression in late life is frequently associated with medical comorbidity. 44 Other studies may have been limited by relatively small sample size, 45 effect of medication, or the current mood state. 46 Meanwhile, other investigators also found that selected samples of MDD patients free of medical comorbidity showed a decrease in CG volume when compared with controls. 47 However, a meta-analysis showed increased gray matter in the cingulate cortex in medication-washout patients. 48 The GMV of cingulate regions in these studies varied. The main factors of such inconsistent results may include mixed samples of patients with MDD. A previous study reported that the PCG was innervated by the serotonergic system, 49 which is associated with vulnerability or pathophysiology of depression. 50 Some studies suggested it may play an important role in the integration of emotional behaviors 51 and in the interactions between emotion and cognition. 52 Vogt et al reported that the PCG may partially underlie self-referential emotional processing, 53, 54 and it has been further identified to be preferentially involved in affective evaluation of incoming stimuli, crucial to the initiation of aggression. 
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anatomical and functional brain abnormalities in MDD Figure 1 regions where there are gray-matter volume abnormalities between unmedicated major depressive disorder patients and healthy controls. Notes: Significant group differences were identified by t-test (P,0.001, uncorrected, cluster size greater than 150 voxels). The color bar represents the t-values of two sample t-test. regions with increased gray-matter volume in patients were located in (A) the left posterior cingulate gyrus; regions with decreased gray-matter volume in patients were located in (B) the left lingual gyrus. Abbreviations: l, left; r, right.
Figure 2 regional homogeneity abnormalities during resting-state functional imaging between unmedicated major depressive disorder patients and healthy controls. Notes: Significant group differences were identified by t-test (P,0.001, corrected for multiple comparisons with the alphasim program). The color bar represents the t-values of two sample t-test. regions showing increased regional homogeneity in patients were located in (A) the left precuneus; regions with decreased regional homogeneity in patients were located in (B) the left putamen. Abbreviations: l, left; r, right.
Besides, the LG was reported to be involved in the visual recognition network and play a key role in global aspects of figure recognition 56 and object naming. 57 In addition, it was believed to be involved in the perception of emotions when facial stimuli were presented. Much evidence has shown that anatomical changes in the PCG and LG may be associated with dysfunction of emotional processing 53, 58, 59 and play a role in emotional processing related to episodic memory. 60 Alterations in ReHo reflect functional brain spontaneous neuronal activity, and previous findings of ReHo have indicated that alterations in regional spontaneous activity existed in depression subjects, especially in MDD. 61 On one hand, increased ReHo values in the precuneus has been reported in early onset treatment-naïve depressions. 62 The authors suggested that the average ReHo values in this region could serve as biomarkers to distinguish patients with early onset Abbreviations: gMV, gray-matter volume; reho, regional homogeneity; haM-D, hamilton Depression rating scale; haM-a, hamilton anxiety rating scale.
depression from individuals with late-onset depression. In the current study, ReHo values of depression patients were found to be increased in the posterior components of the default mode network (precuneus), which was implicated in broad-based continuous sampling of external and internal environments and appeared to serve an important adaptive function. In addition, the alteration in brain regional activity in this region may be implicated in working memory dysfunction 63 and may be associated with the cognitive processing of depression. 64, 65 On the other hand, decreased brain activity in the putamen is consistent with a previous study. 66 A study further reported that decreased ReHo value in the putamen plays a key role in planning and execution of a self-generated novel action. 67 All these findings suggest that abnormalities in the precuneus and putamen may be associated with execution function and play a crucial role in the pathogenesis of depression.
As mentioned earlier, brain structural and functional changes may play a different role in depression. Our current study found that anatomical and resting-state functional deficits existed in different brain regions as a dissociation pattern of brain structural and functional deficits in MDD, especially in GMV and ReHo analysis. Some researchers have found a dissociation pattern of morphometric and functional abnormalities in psychiatric disorders, such as schizophrenia 30, 68 and depression. 33 To the best of our knowledge, this is the first study to use VBM-DARTEL and ReHo methods to reveal both anatomical and functional alterations simultaneously in the same unmedicated patients with MDD. These findings have generated some possible explanations. As a previous study speculated, the dissociation pattern may have resulted from different analysis methods. 33 Structure MRI is used to identify anatomical deficits in gray matter, while fMRI is used to investigate resting-state functional alterations in gray matter. On the other hand, anatomical and functional abnormalities might play different roles in the disease and contribute independently to the neurobiology of MDD. Anatomical alterations evolve in a relatively static or slow process, 68 which may represent more stable and long-standing changes. 69, 70 Nevertheless, functional deficits may represent physiological changes related to the acute-illness stage, 71 and may be normalized after treatment or clinical remission. 72, 73 Furthermore, some studies have reported that anatomical alterations in brain regions may correlate with rumination 74 or suicide attempts in depression patients, 75 while functional alteration of the brain was found to be possibly related to refractoriness to treatment. The latter change might be an imaging marker for predicting future depression recurrence. 76 From the current study, we tentatively speculate that structural and functional deficits are distributed in different brain regions in the same sample of MDD patients, thus providing evidence for the dissociation of the GMV and ReHo changes in depression. The strength of our study was the inclusion of medication-free patients, excluding the possibility of medication. Still, our study had four limitations. First, the small sample size may have reduced the general definitiveness of our results, and well-designed studies with a larger sample size are needed. Second, we did not obtain life-duration data of 
2421
anatomical and functional brain abnormalities in MDD the patients. It is therefore difficult to conclude an association between brain alterations and disease duration. Third, neuropsychological tests were not performed in our study. Fourth, although a dissociation pattern of brain regions with GMV and ReHo alterations was observed in unmedicated patients with MDD, the potential roles of functional and structural changes and the interaction between them need further exploration. Finally, a follow-up study is needed to clarify the relationship between depression and those significant brain alterations.
Conclusion
Our study suggests a dissociation pattern of brain regions with anatomical and functional alterations in unmedicated patients with MDD, especially with regard to GMV and ReHo. This finding implies that functional and anatomical abnormalities of brain regions might contribute independently to the pathophysiology of MDD.
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